title: Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysis.
authors.affiliation: Mount Sinai School of Medicine, 35 East 85th Street, New York, NY 10028, USA. zbloomgard@aol.com
authors.forename: Zachary T
authors.initials: ZT
authors.lastname: Bloomgarden
authors.forename: Regina
authors.initials: R
authors.lastname: Dodis
authors.forename: Catherine M
authors.initials: CM
authors.lastname: Viscoli
authors.forename: Eric S
authors.initials: ES
authors.lastname: Holmboe
authors.forename: Silvio E
authors.initials: SE
authors.lastname: Inzucchi
mesh_terms: D001786:Blood Glucose / Q000032:analysis*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D012044:Regression Analysis
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents